ARRIGE logo-banner
About us Meetings Documents News Blog Forum
.

Initial ARRIGE meetings

1st Albrecht Müller ARRIGE (AMA) seminar on "All you want to know on Gene Drive", 23 September 2021, ONLINE

2020 ARRIGE ANNUAL MEETING, 14 November 2020, ONLINE

Vector-Borne Diseases, Nature and Genome Editing: An Ethical Consultation, at Medical University of Vienna, 8-9 January 2020, Vienna, Austria

ARRIGE ANNUAL MEETING, at CRI, 14 November 2019, Paris, France

ARRIGE KICK-OFF MEETING, 23 March 2018, Paris, France

Introducing the ARRIGE initiative at the IMPC/Infrafrontier meeting, 16 November 2017, Athens, Greece

FOSTERING RESPONSIBLE RESEARCH WITH CRISPR-Cas9, 13 November 2017, Paris, France

1st Albrecht Müller ARRIGE (AMA) seminar

23 September 2021 - ONLINE - 2:00/5:00PM CET - Paris time

All you want to know on Gene Drive

Booklet of this 1st AMA Seminar on GENE DRIVE

  • Albrecht Müller was Professor at the Institute of Medical Radiation and Cell Research at the University of Würzburg and was our link with the Berlin-Brandenburg Academy of Sciences and Humanities. Albrecht Müller was an early and active supporter of the concept and aims of ARRIGE and, as such, he contributed to its launching in early 2018, up to his untimely death in September 2019.

  • PURPOSE: The purpose of the Albrecht Müller’s ARRIGE Seminars is twofold. From a general standpoint, its mission is to provide a forum for ARRIGE members and followers to update their knowledge on the scientific and ethical issues of a particular topic linked to gene editing. Secondly, and above all, the seminar seeks to serve as a repository for new insight and policy recommendations by our members on the topic treated in the seminar.
  • SCOPE: Each seminar will be devoted to one particular area of gene editing. Our first seminar will be on the topic of gene drive. The three-hour seminar will begin with a presentation of the latest science in the chosen subject. The rest of the seminar will be devoted to two roundtables that will explore the ethical, social, economic and political ramifications of the chosen topic, and conclude with ARRIGE members’ input on governance and public engagement initiatives.


Registration for this 1st AMA Seminar on GENE DRIVE

(registration closed)

Priority and free for ARRIGE members with the 2021 annual fee duly paid

Free but first come/first serve for non-ARRIGE members up to maximum capacity (100 participants)


Introduction (2pm – 2:10pm)

Lluis Montoliu, ARRIGE President

Scientific Introduction on Gene Drive. (2:10pm – 2:30pm)

Eric Marois (Institute of Molecular and Cell Biology, CNRS-Inserm-University of Strasbourg, France)

Roundtable 1: Implications of the in vivo use of Gene Drive. (2:30pm – 3:30pm)

Moderator: Jerome Singh (ARRIGE Scientific committee)

Laura Norris (Vector Control Malaria Program, Melinda and Bill Gates Foundation, USA), Diabate Abdoulaye (Institut de Recherche en Sciences de la Santé/Centre Muraz Bobo Dioulasso, Burkina-Faso, Africa) & John Connolly (Senior Regulatory Science Officer, Imperial College London, UK)

Roundtable 2: Social and ethical implications of Gene Drive. (3:30pm – 4:30pm)

Moderator: Jennifer Merchant (ARRIGE, Deputy Treasurer)

Anna Deplazes Zemp (Center for Ethics, University of Zurich, Switzerland), Katherine Littler (Global Health Ethics & Governance Unit, WHO) & Michael Santos (GeneConvene Global Collaborative, The Foundation for the National Institutes of Health, USA)

General Discussion with the Public (4:30pm – 4:50pm)

Moderator: Christiane Drüml (UNESCO Chair on Bioethics, the Medical University of Vienna, Austria)

Conclusion (4:50pm – 5pm)

Hervé Chneiweiss, ARRIGE Vice-President

ARRIGE web site prepared by Lluís Montoliu - Last modified: 21 September 2021